IP Group plc is a leading intellectual property commercialization company that specializes in technology transfer and investment. The company collaborates with universities and research institutions to transform scientific innovation into business opportunities.

David Norwood

IP Group plc

Parkwalk Advisors

Kiko Ventures

IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

WaveOptics

Xeros

Actual Experience

Talivest

Tissue Regenix

Avacta Group

Mirriad

Moltin

Abliva AB

import.io

Inivata

Intelligent Ultrasound

Oxford Nanopore Technologies

Diurnal Group

Dukosi

Exyn Technologies

Perpetuum

Refract

Beijing Galaxy World Group

Some great news from portfolio company Pulmocide yesterday, which shared successful results from its Phase 2 safety study of its investigational product, inhaled opelconazole. 

Read more: https://bit.ly/4cXIiH0

#LifeSciences #PulmonaryAspergillosis

🏆Congratulations to Hysata who have won the SME Sustainable Leadership Award 

Last week, Shane Meaney and Nadine C. from IP Group plc’s Melbourne Office were pleased to attend the 35th National Banksia Foundation Sustainability Awards, to support portfolio company Hysata.

Well done to the whole team on this amazing achievement!

#GreenHydrogen #Sustainability 

An exciting milestone from portfolio company Genomics plc, which has today announced a ground-breaking partnership with MassMutual, bringing an innovative approach to health and wellness.

Read more here: https://bit.ly/3VN0gWI

#Genomics #PreventativeCare

IP Group plc is the UK’s most active investor in science-based companies, with a focus on life sciences, deeptech and cleantech.

Edison’s Dan Ridsdale recently caught up with Greg Smith, CEO of IP Group.

https://lnkd.in/ejM4WnkH

Metric
Company Name	IP Group plc
Symbol
MSH ID	COM:IPGROUPPLC
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital & Private Equity
Country	GB
Stage
Employee Count	254
Website	ipgroupplc.com
LinkedIn	ip-group-plc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:IPGROUPPLC

IP Group plc

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue